2025-12-11T11:33:40-00:00 2025-07-31 990 2024-08-01 203620169 Partnership for Cures % Barbara Goodman PART 8477451246 134 N LaSalle Street STE 1130 Chicago IL 60602 Barbara Goodman CEO 8477451246 2025-12-11 false true 2024 2025-03-06 01:10:19Z Cures Within Reach Barbara Goodman 134 N LaSalle Street STE 1130 Chicago IL 60602 3912759 false X WWW.CURESWITHINREACH.ORG X 2005 IL To help patients by raising funds to find, vet, finance manage pilot human clinical trials that test already approved drugs, devices and other products to deliver fast, safe and affordable treatments for both common 9 9 4 130 0 1466673 3555268 0 201885 241482 108738 84566 1777296 3881316 1001690 644592 0 438197 501810 0 67026 167487 163845 1607374 1310247 169922 2571069 4893129 7498255 1458774 1480635 3434355 6017620 Cures Within Reach leverages the speed, safety and cost-effectiveness of testing approved therapies for new indications/diseases without effective treatment driving more treatments quicker to more patients. false false 1130455 644592 Repurposing research In its main area of focus, the organization catalyzes clinical trials testing approved therapies by finding and facilitating these proof-of-concept clinical trials that, when succesful, catalyze follow-on funding for further trials and publications in order to allow broad patient use. In FY 2025 11 new clinical repurposing trials were signed in infectious disease, maternal health, neurology, oncology, rare disease and other disease areas, 9 clinical trials were completed, and 41 trials were still in progress for a total of 52 ongoing trials as of July 31, 2025. 1130455 true true false false false false false false false false true false false false false false true false false false true true false false true false false true false true false false false false false false false false false false false false false false false false false false false false true 9 0 true 4 true false false false false false true true false false false false false false X 9 9 false false false false false false false true true false false true true true true true true true false false IL X Barbara Goodman 8477451246 134 N La Salle Str Ste 1130 Chicago IL 60602 Barbara Goodman President and CEO 040.00 X 205320 0 8213 Margaret Christie Chairman 002.00 X X 0 0 0 Matthew Rich Treasurer 001.00 X X 0 0 0 Lucy Mancini-Newell Secretary 001.00 X X 0 0 0 Kristina Allikmets Director 001.00 X 0 0 0 Steve Braun Director 001.00 X 0 0 0 Don Lo Director 001.00 X 0 0 0 Robert Metz Director 001.00 X 0 0 0 Nancy Sullivan Director 001.00 X 0 0 0 Eric Waehner Director 001.00 X 0 0 0 205320 8213 1 false true false 3555268 3555268 241482 241482 116009 31443 84566 84566 3881316 326048 255226 255226 0 389366 389366 0 212414 139131 42483 30800 0 220233 171781 37440 11012 0 38262 27740 7270 3252 30901 22346 5675 2880 22555 20250 2255 50 0 21841 16381 4368 1092 0 0 0 0 15792 10827 3094 1871 3169 1243 1780 146 0 36944 27708 7389 1847 0 0 3724 3661 63 0 0 628 596 16 16 3425 2569 685 171 Program development 54209 40461 13748 Other 1558 1169 311 78 0 1310247 1130455 112766 67026 1519133 1394531 138366 1299397 3602 5342 153627 9517 942 144110 3190547 4601842 40539 53033 4893129 7498255 34282 182569 1424492 1298066 1458774 1480635 X 1129127 1657072 2305228 4360548 3434355 6017620 4893129 7498255 2571069 12196 X false true X true false X 1958632 1395438 2067538 1466673 3555268 10443549 1958632 1395438 2067538 1466673 3555268 10443549 6782263 3661286 6734 7403 106218 201885 241482 563722 11007271 0.33260 0.37568 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false 153627 9517 144110 144110 Financial derivatives and other financial products Closely-held equity interests Federal income taxes 3640338 504 504 3639834 241482 241482 3881316 1310751 504 504 1310247 1310247 XI 4b Investment income reported in Form 990, reported under non operating activities on audit report. true Sub-Saharan Africa Research 65000 Wire Transfer Sub-Saharan Africa Research 65000 Wire Transfer South Asia Research 65000 Wire Transfer Sub-Saharan Africa Research 64378 Wire Transfer Sub-Saharan Africa Research 64988 Wire Transfer Sub-Saharan Africa Research 65000 Wire Transfer 6 Part I Line 2 Grants recipients are obligated by signed agreement to provide our Organization with semi-annual research or annual research progress reports and financial reports. Funds are distributed only on a schedule of achieved research progress. Part II Line 1 Grants are reported on the accrual basis,the accounting method used by the Organizations financial statements. Miller Golf 71026 71026 204 11269 1744 golf 2025 44983 44983 78 16900 1248 116009 116009 282 28169 2992 31443 84566 true University of Colorado - Denver PO Box 910238 Denver CO 80291 846000555 501c3 60000 Reserach/Clinical Trials University of Chicago 5841 S Maryland Ave MC 8042 Chicago IL 60637 362177139 501c3 80000 Reserach/Clinical Trials University of Illinois 1737 Polk Str 304 AOB Chicago IL 60612 376000511 501c3 90000 Reserach/Clinical Trials University of California Davis 1 Shields Ave Mrak Hall Davis CA 95616 946036494 501c3 60000 Reserach/Clinical Trials Virginia Commonwealth University 800 East Leigh St Richmond VA 23298 546001758 501c3 15000 Reserach/Clinical Trials The Washington University St Louis One Brookings Dr St Louis MO 63130 430653611 501c3 60000 Reserach/Clinical Trials Northwestern University 750 N Lake Shore Dr Chicago IL 60611 362167817 501c3 20000 Research 6 1 true X X X false false false false false false false false false Barbara Goodman President and CEO 191100 14220 8213 213533 Form 990, Part VI, Section B, Line 11b Form 990 is made available to the Board of Directors for review prior to e-filing with the IRS. Form 990, Part VI, Section B, Line 12c Annually, actual and potential conflicts of interest are reviewed by each Board member, signed and returned. Form 990, Part VI, Section B, Line 15b CEOs compensation is reviewed annually using comparability data. Form 990, Part I, Line 1 and rare disorders without effective treatment.